Koen Van Laere

TL;DR: Validation of the 18F‐labeled PIB derivative18F‐flutemetamol could significantly enhance access to in vivo β‐amyloid imaging technology.

TL;DR: Findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE ε4 status.

TL;DR: These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee and includes an update in the light of advances in PET technology, the introduction of hybrid PET/CT systems and the broadening clinical indications for FDG brain imaging.

TL;DR: Autoradiographic studies in rhesus monkey brain showed that [18F]MK-9470 binding is aligned with the reported distribution of CB1 receptors with high specific binding in the cerebral cortex, cerebellum, caudate/putamen, globus pallidus, substantia nigra, and hippocampus, and PET imaging studies in human research subject demonstrated behavior very similar to that seen in monkeys.